Nova Eel Inc.'s new medicated product Estradiol has been added to the FDA Designations List.  

The intended use is for the new product is increased rate of weight gain and improved feed efficiency in American eels fed in recirculating aquaculture systems.

Designation is a status that makes a pharmaceutical sponsor eligible for incentives to support drug approval. Designation does not allow the drug to be marketed (sold, promoted, or advertised).

The product received the designation on 7/26/2017, and is included as number 138 in the Designations List.